Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
10/30/1991 | EP0453497A1 Treatment methods and vaccines |
10/30/1991 | CN1055732A Novel alpha-mannosidase and fucosidase inhibitors |
10/29/1991 | US5061806 Phosphinic acid derivatives |
10/29/1991 | US5061804 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives and processes for the preparation thereof |
10/29/1991 | US5061712 Bactericides |
10/29/1991 | US5061702 Cephem compound as an antimicrobial agent |
10/29/1991 | US5061623 Peptides comprising an immunogenic site of poliovirus and dnas containing nucleotide sequences coding for these peptides |
10/29/1991 | US5061622 Process for the production of κ-casein glycomacropeptide |
10/29/1991 | CA2040940A1 5-(1,2,4-triazol-1-ylmethyl)-isoxazolines |
10/29/1991 | CA1291486C Quaternary ammonium salts possessing antimicrobial activity and methods for preparation and use thereof |
10/28/1991 | WO1991016927A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
10/28/1991 | CA2081478A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
10/28/1991 | CA2041246A1 Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents |
10/28/1991 | CA2040866A1 Antimicrobial compositions and process for preparing the same |
10/28/1991 | CA2039789A1 Calicheamicinone, derivatives and analogs thereof and methods of making the same |
10/27/1991 | CA2041175A1 Carboxylic acid derivatives |
10/26/1991 | WO1991016049A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
10/26/1991 | CA2081346A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
10/25/1991 | WO1991016320A1 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents |
10/24/1991 | CA2040510A1 Composition and treatment with biologically active peptides and toxic cations |
10/23/1991 | EP0453337A2 Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmic use |
10/23/1991 | EP0453216A2 The use of autologous promoters to express gene products in bordetella |
10/23/1991 | EP0453097A2 Zusammensetzung enthaltend zumindest zwei verschiedene Antikörper oder deren Fragmente |
10/23/1991 | EP0453024A1 Actinobacillus pleuropneumoniae subunit vaccine |
10/23/1991 | EP0452935A1 Chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents |
10/23/1991 | EP0452908A2 Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids |
10/23/1991 | EP0452680A1 Substituted purines, process for their preparation and their use as antiviral agents |
10/23/1991 | CN1055541A Improved meninggococcal polysaccharide conjugate vaccine |
10/23/1991 | CN1055485A Stable primycin agueous solution, composition of pharmaceutical and protective skin agent containing same and process for their preparation |
10/22/1991 | US5059615 Treatment of mycoses |
10/22/1991 | US5059597 Animal growth regulators; enterobacter |
10/22/1991 | US5059592 Composition for prevention and (or) treatment of AIDS |
10/22/1991 | US5059537 Acellular vaccine |
10/22/1991 | CA1291136C Quinoline derivatives, their preparation and therapeutic compositions containing the same |
10/22/1991 | CA1291125C Pyrimidine derivatives |
10/22/1991 | CA1291054C Antitumor antibiotics (ll-e33288 complex) |
10/22/1991 | CA1291038C Method for preventing coloration of aqueous preparations of cefmenoxime |
10/21/1991 | WO1991016333A1 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
10/21/1991 | CA2080916A1 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
10/20/1991 | CA2040608A1 Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids |
10/19/1991 | WO1991016334A1 Erythromycin derivatives |
10/19/1991 | CA2080583A1 Erythromycin derivatives |
10/19/1991 | CA2039566A1 Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use |
10/17/1991 | WO1991015603A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
10/17/1991 | WO1991015587A1 Self-polymerising expression system based on modified potyvirus coat proteins |
10/17/1991 | WO1991015586A1 Improvements relating to the detection of viruses |
10/17/1991 | WO1991015572A1 Live vaccines |
10/17/1991 | WO1991015500A1 Oligonucleotide analogs |
10/17/1991 | WO1991015238A1 Methods and compositions for vaccination against hiv |
10/17/1991 | WO1991015237A1 Compositions and treatments for pneumonia in animals |
10/17/1991 | WO1991015227A1 Method and compositions for treating injury |
10/17/1991 | WO1991015224A1 Inhibition of disease associated with immunodeficiency virus infection |
10/17/1991 | WO1991015212A1 Antiviral compositions and method for their use |
10/17/1991 | WO1991015208A1 Veterinary treatment |
10/17/1991 | WO1991015200A2 Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases |
10/17/1991 | WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
10/17/1991 | CA2079803A1 Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases |
10/17/1991 | CA2078546A1 Methods and compositions for vaccination against hiv |
10/16/1991 | EP0451957A2 Cyclohexapeptide compound |
10/16/1991 | EP0451834A2 Alpha-mannosidase and fucosidase inhibitors |
10/16/1991 | EP0451764A1 Carbapenem compounds |
10/16/1991 | EP0451486A1 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T |
10/16/1991 | EP0451211A1 Cloning and production of polypeptide analogs of human fibronectin and method of using such polypeptide analogs |
10/16/1991 | EP0277151B1 Novel medicinal use of nucleosides |
10/16/1991 | CN1055362A Hydroxymethyl-indolizidines and quinolizidines |
10/15/1991 | US5057614 Substituted pyrroles |
10/15/1991 | US5057511 Antibiotics, bactericides |
10/15/1991 | US5057423 Method for the preparation of pure LAK-active lymphocytes |
10/15/1991 | US5057411 For identifying specific viruses |
10/15/1991 | CA1290751C Process for preparing netilmicin |
10/11/1991 | CA2039968A1 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them |
10/10/1991 | WO1991015499A1 2'-o-alkyl nucleotides and polymers containing them |
10/10/1991 | DE4037363A1 New 2-O-alkyl nucleotide(s) and polymers contg. them - for nuclease-resistant anti-sense probes and to treat viral infection including herpes influenza and AIDS and cancer |
10/10/1991 | CA2039987A1 Carbapenem compounds |
10/09/1991 | EP0451082A1 Ophthalmic product |
10/09/1991 | EP0450812A1 Antihypercholesterolemics |
10/09/1991 | EP0450588A1 Substituted 3-thia- or 3-oxa-alkyl flavones, process for their preparation, their application and drugs based on these compounds as well as intermediates |
10/09/1991 | EP0450573A2 Antibodies for the treatment and diagnosis of Pseudomonas aeruginosa infections |
10/09/1991 | EP0450240A1 Anti-aids preparation |
10/09/1991 | EP0449972A1 Triple stranded nucleic acid and methods of use |
10/09/1991 | EP0449871A1 Method for predicting biological activity of antibiotics, and novel non beta-lactam antibacterial agents derived therefrom |
10/09/1991 | EP0449856A1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
10/09/1991 | EP0207124B1 Use of podophyllotoxin and derivatives thereof |
10/09/1991 | CN1014246B Prepn. of carbapemem compounds |
10/08/1991 | US5055572 Antiobiotics |
10/08/1991 | US5055458 Purine derivatives having antiviral activity |
10/08/1991 | US5055457 Pharmaceutical combinations product and the preparation and use thereof |
10/08/1991 | US5055455 Inhibiting adhesion of coagulase-negative staphylococcus to a polymeric material |
10/08/1991 | US5055447 Administering transforming growth factor beta |
10/08/1991 | US5055446 Less than ten percent of calories from protein, remainder is from lipids and carbohydrates |
10/08/1991 | CA1290339C Quinolonecarboxylic acid derivative and process for its preparation |
10/08/1991 | CA1290338C Quinolonecarboxylic acid derivatives |
10/08/1991 | CA1290332C Substituted 2-phenylhexahydro-1,2,4-triazine-3,5- diones, a process for their preparation, agents containing them, and their use |
10/08/1991 | CA1290248C Treatment of infections with lymphokines |
10/08/1991 | CA1290243C Biocidal, particularly virucidal, compositions |
10/07/1991 | CA2038978A1 Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections |
10/05/1991 | WO1991015505A1 Purification of a pertussis outer membrane protein |
10/05/1991 | WO1991015498A2 Nucleoside derivatives |
10/05/1991 | WO1991015488A1 Carbo-nucleoside derivatives |
10/05/1991 | CA2359307A1 Pertussis outer membrane protein |